Heinz Lehmann

Heinz Lehmann's AcademicInfluence.com Rankings

Heinz Lehmann

Biology

#8585

World Rank

#11685

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Heinz Lehmann Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Heinz Edgar Lehmann was a German-born Canadian psychiatrist best known for his use of chlorpromazine for the treatment of schizophrenia in 1950s and "truly the father of modern psychopharmacology."

(See a Problem?)

Heinz Lehmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients (1977) (230)
Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states. (1954) (208)
The History of the Psychopharmacology of Schizophrenia (1997) (90)
Yawning. A homeostatic reflex and its psychological significance. (1979) (87)
An 11‐year follow‐up study of 110 depressed patients (1988) (63)
The Treatment of Depressive Conditions with Imipramine (G 22355) * (1958) (62)
Psychopharmacological treatment of schizophrenia. (1975) (59)
Observations on the Action of Sernyl — A New Psychotropic Drug (1961) (57)
Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. (1967) (56)
Experimental sleep deprivation in schizophrenic patients. (1960) (56)
Sexual behavior of the male schizophrenic: The impact of illness and medications (1981) (53)
TIME AND PSYCHOPATHOLOGY (1967) (53)
Neurological side effects of lithium: organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. (1980) (46)
Beta-Endorphins and Naloxone in Psychiatric Patients: Clinical and Biological Effects (1979) (45)
Therapy-resistant depressions - a clinical classification. (1974) (44)
Side effects and teratogenicity of lithium carbonate treatment. (1970) (41)
Differential screening of phrenotropic agents in man: psychophysiologio test data. (1957) (40)
Clinical evaluation and natural course of depression. (1983) (39)
Psychiatric Concepts of Depression: Nomenclature and Classification (1959) (39)
Before They Called It Psychopharmacology (1993) (38)
A double-blind, placebo-controlled dose-finding study with sertraline. (1989) (38)
Epileptic Munchausen's syndrome (1988) (34)
Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. (1970) (32)
Minimal maintenance medication: effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients. (1983) (31)
Affective disorders in the aged. (1982) (31)
Skin Pigmentation, A Rare Side Effect of Chlorpromazine (1965) (26)
β-Endorphin therapy in psychiatric patients (1979) (23)
Beta-endorphin--induced changes in schizophrenic and depressed patients. (1977) (22)
Controlled Evaluation of Nicotinamide Adenine Dinucleotide in the Treatment of Chronic Schizophrenic Patients (1967) (21)
Nicotinic Acid in the Prevention and Treatment of Methionine-Induced Exacerbation of Psychopathology in Schizophrenics * (1970) (21)
RATING THE RATER. AN EXPERIMENTAL APPROACH TO THE METHODOLOGICAL PROBLEM OF INTERRATER AGREEMENT. (1965) (20)
Pimozide in the treatment of chronic schizophrenic patients. (1970) (20)
Potentiation of Therapeutic Effects of Nicotinic Acid by Pyridoxine in Chronic Schizophrenics * (1973) (19)
Clinical trial with desmethylimipramine (G-35020), a new antidepressive compound. (1962) (19)
A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. (1970) (17)
Pharmacotherapy of tension and anxiety. (1972) (17)
The use of finger paintings in the clinical evaluation of psychotic conditions: a quantitative and qualitative approach. (1953) (17)
Environment and Psychopathology (1993) (16)
Negative findings with megavitamins in schizophrenic patients: preliminary report. (1977) (16)
A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients. (1970) (16)
A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients. (1973) (16)
A comparison of desipramine and amitriptyline plasma levels and therapeutic response. (1978) (15)
Nicotinic Acid in the Treatment of Schizophrenias * : Summary Statement Progress Report I Canadian Mental Health Association Collaborative Study (1970) (14)
Fluspirilene in the treatment of chronic schizophrenic patients. (1970) (14)
Treatment of depression with dexedrine and demerol. (1971) (14)
Neuroleptic drugs and sexual function in schizophrenia. (1980) (14)
Therapy of Phenothiazine-produced skin pigmentation: a preliminary report. (1966) (13)
BEHAVIOURAL REACTIONS TO TRIAZOLAM (1979) (13)
Clinical perspectives on antidepressant therapy. (1968) (13)
The differential effects of viloxazine and imipramine on performance tests: their relationship to behavioural toxicity. (1980) (13)
Metronidazole in the treatment of the alcoholic. (1966) (12)
RECOMMENDATIONS for reporting studies of psychiatric drugs. (1957) (12)
Beta-endorphine-induced changes in schizophrenic and depressed patients N.S. Kline, C.H. Li, H.E. Lehmann, A. Lajtha, E. Laski and T. Cooper, Arch. gen. Psychiat., 34 (1977) 1111–1113 (1979) (12)
A review of nicotinic acid, N-methylated indoleamines and schizophrenia. (1978) (12)
beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects. (1979) (12)
A preliminary investigation of WY-3263 versus amitriptyline in depressions. (1968) (12)
Adynamic ileus during psychoactive medication. (1967) (11)
A Homeostatic Reflex and Its Psychological Significance (1979) (11)
Nicotinic Acid in the Treatment of Schizophrenias: Canadian Mental Health Association Collaborative Study Progress Report II * (1975) (11)
Phenomenology and pathology of addiction. (1963) (11)
Psychometric tests in evaluation of brain pathology, response to drugs. (1970) (10)
Problems of differential diagnosis and choice of therapy in depressive states. (1965) (10)
Selection and Prediction of Therapeutic Responsiveness in Geriatric Patients * (1968) (10)
SELECTIVE INHIBITION OF AFFECTIVE DRIVE BY PHARMACOLOGICAL MEANS (1954) (10)
The Future of Psychiatry: Progress — Mutation — or Self Destruct? * (1986) (10)
The advantages of nitrous oxide inhalation in psychiatric treatment. (1947) (9)
Handbook of Psychiatric Treatment in Medical Practice (1964) (9)
Lack of indication for use of antiparkinson medication. A follow-up study. (1971) (9)
Comprehensive clinical studies with trazodone. (1973) (9)
Studies on the iron content of cerebrospinal fluid in different psychotic conditions. (1951) (9)
Stress dynamics in psychiatric perspective. (1952) (8)
The use of methyldopa in schizophrenia: a review and comparative study. (1972) (8)
A standard-controlled clinical study with trazodone in schizophrenic patients. (1977) (8)
THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME. (1965) (8)
The philosophy of long-acting medication in psychiatry. (1970) (8)
A clinical trial with nomifensin, a new antidepressant drug. (1975) (8)
Systematic studies with trimipramine--a new antidepressive drug. (1967) (8)
Negative aspects of psychotherapeutic drug treatment. (1979) (8)
Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function. (1971) (8)
Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid. (1977) (8)
Nicotinic Acid, Thioridazine, Fluoxymesterone and their Combinations in Hospitalized Geriatric Patients * : A Systematic Clinical Study (1972) (8)
Psychopharmacological approaches to the organic brain syndrome. (1983) (8)
Diphosphopyridine nucleotide in the treatment of schizophrenia. (1967) (7)
Propericiazine in Psychiatric Emergencies: A controlled comparative study * (1972) (7)
A comparative study of molindone and trifluoperazine. (1970) (7)
A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients. (1976) (7)
Classification of Depressive States * (1977) (7)
Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordings. (1978) (7)
Conditional Reflex Studies in Depression (1966) (7)
Observations on the Clinical Effects of a new Tranquillizing Agent in Psychotic Conditions (1957) (7)
Comparative pharmacotherapy of the aging psychotic patient. (1967) (7)
Diagnosis and treatment of old age dementias (1989) (7)
An adverse reaction unit: results and functions. (1971) (6)
Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients. (1970) (6)
The effect of clopenthixol on chronic psychiatric patients. (1963) (6)
A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients. (1975) (6)
Comprehesiven clinical studies with thiothixene. (1975) (6)
Letters to the EditorSUCCINYLCHOLINE (1952) (6)
Sex differences in long-term adverse effects of phenothiazines. (1974) (5)
A comparison of the hypnotic properties of mandrax and its two constituents. (1968) (5)
The clinician's view of anxiety and depression. (1983) (5)
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161). (1975) (5)
Proceedings: Thyrotropin releasing hormone in depression: clinical and endocrinological findings. (1976) (5)
Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic. (1967) (5)
A Conditioning Test Battery for the Study of Psychopathological Mechanisms and Psychopharmacological Effects * (1970) (5)
Agranulocytosis associated with methotrimeprazine (Nozinan) administration: a report of three cases. (1970) (5)
Urinary incontinence associated with thioridazine administration. (1971) (5)
An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia. (1977) (4)
Psychopharmacological Aspects of Geriatric Medicine (1972) (4)
Notes from the Log-Book of a Psychopharmacological Research Unit I * (1964) (4)
Acquired Transient CNS Hypersensitivity to Lithium Therapy (1980) (4)
Placebo-proneness and placebo-resistance of different psychological functions (1960) (4)
Transference, discrimination and reversal. A comparison between normals and pathological groups. (1972) (4)
Successful Cerebral Aging: Clinical and Pharmacological Approaches to the Aging Brain (2000) (4)
Psychological tests: practice effect in geriatric patients. (1968) (4)
Classification of Affective Disorders and Psychopharmacology: Rosetta Stone or Hypothetical Construct? (1989) (4)
Psychopharmacotherapy in Psychogeriatric Disorders (1979) (4)
Differential effects of trazodone in depressed, schizophrenic and geriatric patients. (1974) (4)
Systematic clinical studies with trazodone: methodological aspects. (1973) (3)
Effects of psychoactive drugs on conflict avoidance behavior in human subjects. (1971) (3)
Clinical evaluation of a new psychotropic drug--molindone. (1970) (3)
The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients. (1967) (3)
Attempt to classify psychotropic drugs, based on their affinity to mucopolysaccharides in vivo. (1962) (3)
New Types of HOSPITAL-COMMUNITY FACILITIES (1958) (3)
Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change. (1976) (3)
Developmental norms on four psychophysiological measures for use in the evaluation of psychotic disorders. (1958) (3)
The effect of hypnotics on rapid eye movement (REM). (1968) (3)
Non-tricyclic and non-monoamine oxidase inhibitors. (1982) (3)
Further studies on the iron content of the cerebrospinal fluid in psychoses. (1952) (3)
Clinical studies with MO-1255, a new monoamine oxidase inhibitor antidepressant. (1966) (3)
Combined pharmaco-fever treatment with imipramine (tofranil) and typhoid vaccine in the management of depressive conditions. (1960) (3)
Mesoridazine in acute psychotic disturbances. (1967) (3)
Efficacy of haloperidol in drug refractory patients. (1967) (3)
Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients. (1966) (3)
Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined. (1968) (3)
Additional Notes and Comments (1963) (3)
Protrptyline in the treatment of chronic schizophrenic patients. (1970) (3)
A clinical trial of thiothixene (Navane) in schizophrenics. (1967) (3)
A placebo-controlled clinical study with trazodone in schizophrenic patients. (1977) (3)
Notes from the Log-Book of a Psychopharmacological Research Unit II * (1964) (2)
Conditional reflex studies in the schizophrenias. (1971) (2)
[Preliminary report on the therapeutic action of flagyl in alcoholism]. (1966) (2)
Neurophysiologic activity of chlorpromazine in clinical use. (1956) (2)
Empathy and perspective or consensus and automation (1967) (2)
Prospects in Postgraduate Education in Psychiatry (1970) (2)
Combined Administration of Thioridazine and Nicotinic Acid in the Treatment of Geriatric Patients (1971) (2)
Uncontrolled study with pipothiazine palmitate. (1973) (2)
A transcultural study with clomacran: comparison of two assessment methods. (1974) (2)
A COMPARATIVE STUDY OF THIRTEEN HYPNOTIC DRUGS. (1964) (2)
Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients. (1972) (2)
A comparative study of salivation in affective disorders. (1980) (2)
[A comparative study of propericiazine in the management of antisocial behavior]. (1967) (2)
Conditioning in the prediction of therapeutic outcome in depressions (1969) (2)
Myths, theories and treatment of schizophrenia. (1977) (2)
Thiothixene and the thioxanthenes. (1974) (2)
Multiple personality in a case of functional psychosis. (1985) (2)
[RELATION BETWEEN PHOTOSENSITIVITY AND PATHOLOGIC PIGMENTATION OF THE SKIN WITH HIGH DOSES OF CHLORPROMAZINE]. (1965) (2)
Combined administration of thioridazine, nicotinic acid, and fluoxymesterone in the treatment of geriatric patients. (1971) (2)
Nomifensin in the treatment of depression: a report on the Canadian part of a transcultural study. (1978) (2)
Discussion: a renaissance of psychiatric diagnosis? (1969) (2)
The Place of Thiothixene in the Treatment of Schizophrenic Patients (1970) (2)
A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients. (1977) (2)
Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia. (1973) (2)
A summary of systematic studies. (1976) (2)
Combined administration of thioridazine and fluoxymesterone in the treatment of geriatric patients. (1970) (2)
CHAPTER 12. SCHIZOPHRENIA 12.7 SCHIZOPHRENIA: CLINICAL FEATURES (2004) (2)
Panel I: On the Organic Sub-Stratum and the Phenomenology of the Depressive Illnesses: On the Phenomenology of the Depressive Illnesses * (1966) (1)
Studies with Thioxanthenes1 (1969) (1)
POTENTIATION OF PHARMACOLOGICAL AND THERAPEUTIC ACTION OF PHENOTHIAZINES BY NYLIDRIN (ARLIDIN). (1964) (1)
CNS stimulants and anabolic substances in geropsychiatric therapy. (1975) (1)
Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report. (1976) (1)
Pharmacotherapy of schizophrenia. (1966) (1)
Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients. (1974) (1)
Test-Retest Performance in Chronic Schizophrenia on the Verdun Conditioning Program * (1972) (1)
R--806--03--01 in the treatment of depression: plasma levels and therapeutic response. (1978) (1)
Is psychiatry approaching a steady state? (1980) (1)
Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations. (1971) (1)
The impact of modern pharmacotherapy on the prognosis of psychiatric patients. (1970) (1)
[A special flicker fusion frequency method for detection of the effects of gerontopharmaceuticals exemplified by the L-eburnamonine study]. (1985) (1)
Anxiety: measurement and methodology: Findings with a conditionning test battery: differential responsiveness to diazepam and doxepin [proceedings]. (1977) (1)
The effect of psychostimulants on psychometric test performance with special reference to conflict avoidance behavior. (1970) (1)
Problems with ethical aspects of psychotropic drug use. (1979) (1)
The Psychotropic Drugs: Their Actions and Applications (1967) (1)
Thiothixene. Its range of therapeutic activity. (1970) (1)
Conditioned Reflex Analysis of Chronic Schizophrenias * (1972) (1)
An uncontrolled in clinical trial carried out in Verdun, Quebec, Canada. (1976) (1)
Dose equivalent for haloperidol and phenothiazines. (1967) (1)
Studies on psychiatric patients undergoing nitrous oxide treatments. (1950) (1)
A dynamic concept of the action of chlorpromazine at physiological and psychological levels. (1956) (1)
An uncontrolled clinical study with EX 11-582A in the treatment of chronic schizophrenic patients. (1977) (1)
Doxepin in the treatment of psychoneurotic patients: a comparison between two clinical settings. (1971) (1)
Conditioning and the classification of the chronic schizophrenic patient (1979) (1)
A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients. (1977) (1)
ECDEU (BPRS) and AMP (PAS) studies compared transculturally. (1975) (1)
Tolbutamide jundice associated with multiple drug therapy. (1970) (1)
The impact of scientific models on clinical psychopharmacology: a psychiatrist's view. (1972) (1)
An uncontrolled clinical trial carried out in Panama City, Panama. (1976) (1)
An introduction to systematic studies. (1976) (1)
USE AND ABUSE OF PHENOTHIAZINES. (1963) (0)
Contents Vol. 152, 1966 (1966) (0)
International Pharmacopsychiatry / Psychopathology and Pictorial Expression / Psychopathologie und bildnerischer Ausdruck / Psychopathologie de lexpression (1968) (0)
Processing of aronia (1985) (0)
Boon for average, bane for excellence. (1970) (0)
Dr. Lehmann replies (1975) (0)
Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study. (1971) (0)
The nature and frequency fo the suicide syndrome, twenty years ago and today, in the english-speaking community of the province of Québec. (1967) (0)
THE FUTURE OF COMMUNICATIONS IN NEURO-PSYCHOPHARMACOLOGY (1978) (0)
The persistence of ambiguity. (1970) (0)
SUMMARY OF THE SESSION (1978) (0)
Proceedings: Benzoctamine in the treatment of neurosis--an uncontrolled clinical study. (1976) (0)
A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital. (1970) (0)
Studies with new drugs in the treatment of convulsive disorders. (1968) (0)
[An inhibiting drug for control and treatment of psychomotoric states of excitability (chlorpromazine, largactil, thorazine, megaphen)]. (1954) (0)
Introduction to the colloquium on new drugs in the treatment of schizophrenia. (1977) (0)
Title Page / Table of Contents / List of Participants / Preface (1969) (0)
Chemotherapy in aged psychiaric patients. (1969) (0)
Viloxazine in the treatment of depression: psychophysical measures and clinical response. (1978) (0)
Transference, discrimination and reversal (1972) (0)
Psychopharmacology is a hybrid science. (1967) (0)
WIN 27,147-2 in the treatment of depression. An uncontrolled clinical study. (1977) (0)
The emotional basis of illness. (1967) (0)
Book Review: Pharmacotherapy of Affective Disorders: Theory and Practice (1987) (0)
The 7th Congress — Prague 1970 (1988) (0)
The psychopharmacological profile--a systematic approach to the interaction of drug effects and personality traits. (1961) (0)
Empathy and perspective on consensus and automation? Implications of the new deal in psychiatric diagnosis. (1967) (0)
Abstracts (1920) (0)
Ascorbic acid levels in chronic psychotic patients. (1975) (0)
The Centre de Psychiatrie in Haiti. (1962) (0)
The 15th annual meeting of the pavlovian society (1976) (0)
Quizzing the expert: clinical criteria for psychosurgery. (1973) (0)
Experimental approaches to psychiatric diagnosis : psychometric, conditioning, and psychopharmacological studies (1971) (0)
PERSPECTIVES IN GERIATRIC NEURO-PSYCHOPHARMACOLOGY (1978) (0)
The Phenomena of Depressions (1962) (0)
[Delirium tremens and other acute alcoholic psychoses]. (1955) (0)
Colloquium on clinical trials with antidepressants--behavioral, psychophysical, and pharmacokinetic measurements: Introduction. (1978) (0)
Early organiform impairment test (OFIT). A new performance test for assessment of early cognitive impairment (1985) (0)
Psychiatric Research in Canada*: Report of the Committee on Research of the Canadian Psychiatric Association, June 1964 (1964) (0)
Psychopharmacolog of cannabis (2006) (0)
Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods. (1976) (0)
On the phenomenology of the depressive illnesses. (1966) (0)
Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study. (1971) (0)
A call to arms for clinical research in Alzheimer's disease (1986) (0)
Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial. (1978) (0)
psychopharmacological treatment of schizophrenia9 (1975) (0)
Abstracts (1921) (0)
[From Binet and Wundt to neuropsychological measurements and behavior scales]. (1983) (0)
An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients. (1977) (0)
Psychoactive drugs and their influence on the dynamics of working capacity. (1960) (0)
A trouble in the brain-mind: self-description of a depressive episode. (1982) (0)
A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I. (1977) (0)
STANDARDS FOR THE CLINICAL STUDY OF ANTIPSYCHOTIC SUBSTANCES (1978) (0)
CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients. (1970) (0)
Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients. (1972) (0)
Clinical observations with beta-endorphin injections. (1978) (0)
[Pigmentation of the skin: rare side effect, following the prolonged administration of high doses of chlorpromazine]. (1965) (0)
Options for treatment of the schizophrenic patient. (1976) (0)
Discussion: Pavlovian Conference on Higher Nervous Activity. V. Psychopharmacology. (1961) (0)
[Clinical experience with meprobamate]. (1957) (0)
Psychopharmacological Procedures (0)
Quantity control in psychiatry. (1968) (0)
The 12th meeting of the Pavlovian Society of North America (1967) (0)
A clinical-pharmacological study with EXP 561. (1967) (0)
Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods. (1975) (0)
Uses and abuses of psychoactive drugs. (1978) (0)
Authors’ Reply: Megavitamin Treatment of Schizophrenia (1975) (0)
New psychoactive drugs in psychogeriatrics. (1976) (0)
TIC LX, The Pharmacotherapy of the Depressive Syndrome (2007) (0)
Depression: the evolution of modern paradigms and concepts. (1986) (0)
Manual of Psychiatric Therapeutics: Practical Psychopharmacology and Psychiatry (1978) (0)
Non-equivalence of anti-psychotic drugs. (1968) (0)
PSYCHOPHARMACOLOGY. A DISCUSSION OF CURRENT PROBLEMS. (1963) (0)
CLINICAL AND PHARMACOLOGICAL APPROACHES TO THE AGING BRAIN (MIND) (1992) (0)
THE PLACEBO RESPONSE AND THE DOUBLE-BLIND STUDY. (1964) (0)
[Effect of placebos in a psychiatric observation war as demonstrated by a clinical trial of a new phenothiazine derivative]. (1958) (0)
Changes in Conditioning Associated with Clinical Improvement in a Group of Schizopnrenics (1966) (0)
Papers presented at the Tenth Annual Meeting of the Pavlovian Society of North AmericaOctober 31-November 1,1969 Princeton, N. J. (1970) (0)
Methods of evaluation of drug effects on the human central nervous system. (1959) (0)
Clinical Observations with Frenquel * in Chronic Schizophrenia (1956) (0)
Socio-psychiatric observations on displaced persons. (1953) (0)
Toxic psychotic syndrome associated with chlorpromazine administration. (1970) (0)
Diagnosis of the dementias. (1989) (0)

This paper list is powered by the following services:

Other Resources About Heinz Lehmann

en.wikipedia.org

What Schools Are Affiliated With Heinz Lehmann?

Heinz Lehmann is affiliated with the following schools:

McGill University